Allurion Technologies Warrants (ALUR.WS)

• Market cap: $160K
• 1 day: -8.53%
• 5 days: -20.71%
• 1 month: -20%
• 3 months: -10.96%
• 6 months: 4.69%
• Year to date: -23.21%
• 1 year: -37.82%
• 5 years: -97.42%
• 10 years: -97.42%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Employees: 137

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

86.98% more ownership

Funds ownership: 5.88% [Q1] → 92.86% (+86.98%) [Q2]

15% more funds holding

Funds holding: 34 [Q1] → 39 (+5) [Q2]

30% less capital invested

Capital invested by funds: $254K [Q1] → $178K (-$75.2K) [Q2]

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4